CVE:KHRN Khiron Life Sciences (KHRN) Stock Price, News & Analysis C$0.04 0.00 (0.00%) As of 05/5/2023 Add Compare Share Share Stock Analysis Stock Analysis About Khiron Life Sciences Stock (CVE:KHRN) Get Khiron Life Sciences alerts:Sign Up Key Stats Today's RangeC$0.04▼C$0.0550-Day RangeC$0.04▼C$0.0452-Week RangeC$0.04▼C$0.21Volume24,000 shsAverage Volume256,268 shsMarket CapitalizationC$9.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Read More Receive KHRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KHRN Stock News HeadlinesKhiron Life SciencesMay 28, 2026 | fool.comPharmadrug Stock (OTC:LMLLF), Quotes and News SummaryMay 23, 2024 | benzinga.comCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.November 5 at 1:00 AM | Decentralized Masters (Ad)Focus: Colombia's cannabis industry in crisis over regulatory, political hurdlesDecember 21, 2023 | msn.comGlobal Cannabis Co. Trading Lower On Announcing Amended European Business Sale DealNovember 17, 2023 | benzinga.comKhiron Life Sciences Announces Update to the Proposed Sale of Its European BusinessNovember 16, 2023 | finance.yahoo.comClosing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)May 24, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Monday (KHRN)May 20, 2023 | theglobeandmail.comSee More Headlines KHRN Stock Analysis - Frequently Asked Questions How have KHRN shares performed this year? Khiron Life Sciences' stock was trading at C$0.04 at the beginning of the year. Since then, KHRN shares have increased by 0.0% and is now trading at C$0.04. What other stocks do shareholders of Khiron Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Khiron Life Sciences investors own include Curaleaf (CURLF), VIVO Cannabis (VVCIF), Aurora Cannabis (ACB), Emerald Health Therapeutics (EMH), Teradyne (TER), HEXO (HEXO) and Neptune Wellness Solutions (NEPT). Industry, Sector and Symbol Stock ExchangeCVE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolCVE:KHRN CIKN/A Webwww.khiron.ca Phone705-527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$46.80 million Net Margins-258.92% Pretax MarginN/A Return on Equity-68.62% Return on Assets-20.79% Debt Debt-to-Equity Ratio6.68 Current Ratio3.08 Quick Ratio0.72 Sales & Book Value Annual SalesC$18.08 million Price / Sales0.51 Cash FlowC$0.01 per share Price / Cash Flow6.67 Book ValueC$0.20 per share Price / Book0.20Miscellaneous Outstanding Shares232,409,000Free FloatN/AMarket CapC$9.30 million OptionableNot Optionable Beta2.64 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (CVE:KHRN) was last updated on 5/5/2023 by MarketBeat.com Staff. From Our PartnersThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis little-known fund tracks gold and pays out weeklyA little-known $15 fund tied to gold could pay you cash every Friday, no mining stock required. In one rece...Investors Alley | Sponsored$250,000/Month- How You Can Learn from President TrumpPresident Trump has reportedly collected up to $250,000 a month from a single fund. Now investors can get a...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Khiron Life Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
